Baidu
map

从SARS到MERS 他们从未改变

2015-06-01 佚名 生物谷

5月29日,国家卫生计生委对外通报,中国出现首例中东呼吸综合征(MERS)确诊病例,系输入性病例。该病例系一名韩国男性,曾与韩国MERS病例密切接触,21日在韩国境内出现不适,26日乘飞机抵达香港,经深圳沙头角口岸入境到达惠州。这是中国确认首例“新非典”病例。 国家卫计委已指导广东省卫计委按照预案开展工作,并派出专家组赴当地指导协助应急处置,并组织专家开展风险评估,研判疫情形势。截至目前,

5月29日,国家卫生计生委对外通报,中国出现首例中东呼吸综合征(MERS)确诊病例,系输入性病例。该病例系一名韩国男性,曾与韩国MERS病例密切接触,21日在韩国境内出现不适,26日乘飞机抵达香港,经深圳沙头角口岸入境到达惠州。这是中国确认首例“新非典”病例。

国家卫计委已指导广东省卫计委按照预案开展工作,并派出专家组赴当地指导协助应急处置,并组织专家开展风险评估,研判疫情形势。截至目前,该病例的38名密切接触者均未发现异常情况。该病例有关情况已向世卫组织、港澳台地区和有关国家通报。

MERS是新型冠状病毒(Coronavirus)感染引起的急性、严重呼吸道疾病,自2012年在沙特阿拉伯出现首例病例后,截至最近确诊病例达1142例,其中465例死亡,死亡率高达40.7%。

美国国家过敏症和传染病研究所发布2012年出现的中东呼吸系统综合症病毒粒子的彩色透射电子显微照片。

引发该疾病的冠状病毒与2003年肆虐中国的非典病毒(SARS)有很多相似之处。MERS潜伏期为2-14天,患者伴有发热、咳嗽和呼吸困难等症状,严重的病例会出现肺功能衰竭和死亡。目前尚无疫苗和治疗药物,但传染性不强。

关于MERS

世界卫生组织29日呼吁,国际社会不必对这种新型冠状病毒恐慌,该病毒没有变异,也不具备持续的人际传播能力。但是世卫组织目前不建议对前往韩国旅行进行限制。上海市公共卫生临床中心教授卢洪洲表示,中国传染病防控体系比较完善,可以有效切断MERS-CoV的传播途径,不会出现大规模疫情

然而,对于明知感染风险未及时报告仍坚持出境、以及密切接触mers病例但却拒绝隔离的韩国人,部分中国人表示愤怒。有一个网友翻出了当年凤凰网的一篇报道解释了这种愤怒:因为当年那场“灾难”太可怕。我们不想再次经历,哪怕你只是带来百分之一的可能。而更多的网友表示,从来不曾想过非典,竟然只是一些人灾难的开始。

那些经历SARS的医务工作者

他们是非典中的医务工作者,也是非典受害者。

杨璐颖 1981年出生的杨璐颖是最年轻的非典后遗症患者之一,原北大医院急诊科护士。“非典刚来的时候,消息封锁,医院所有的医护人员都不知道这种类型感冒的严重性。他们的防护就是薄薄的一层口罩而已。

杨璐颖偶尔会到小汤山疗养院接受治疗。泡温泉是缓解骨坏死病痛最好的方法之一,同时还能在浮力的帮助下锻炼肌肉防止萎缩。

武震 36岁的武震是北京花乡医院的内科护士,非典时正在人民医院急诊科实习。回忆起10年前的那个春天,武震记得“天很暖和,有时下点儿细蒙蒙的小雨,每天都打扮得漂漂亮亮的去上班”。

非典在她懵懵然时迅速袭击,然后强力扭转了她的人生轨迹。非典痊愈四个月后,她查出非典后遗症。全身除了两个肘关节,其余股骨头全部坏死。武震说,确诊那天从医院出来,“我记得,我和我妹妹就站在新街口那儿放声大哭”。此后,她被迫放弃工作,治病成了生活的重心。2013年2月,武震接受了全髋置换手术,现在小汤山医院治疗。因为工资问题,她和单位的关系有点儿僵。“这么多年也不能老生活在埋怨当中,得尽快适应这个状态,给自己找一个新的起点,再找出路吧。”之前学内科的武震想过转行,做心理咨询,“把病治好了,挣自己的钱,花着也舒心。”

毕维杰 原北京朝阳医院医务处处长。2003年3月30日,因参与SARS病人救治工作而感染SARS。她是北京第一例接受气管切开插管的医生。毕维杰回忆,切开气管插管时她已经不需要用麻药,因为完全没有了痛觉。之后的15天,她几乎没有睁眼,不辨昼夜。

当时她工作的朝阳医院专门派了专家组在病房轮流值守,仅存的意识中,她记得每一个来接班的人都会询问,“死了么”,值班的人说“还没”。因为太受罪,她还尝试过拔管,“如果不是医生及时赶到就没命了”。非典康复后,毕维杰的股骨头彻底塌陷,于2007年4月接受人工关节移植手术。据说,这种人工关节使用寿命在10到15年之间,而在那之后将不能再进行第二次的更换术。现在,她的双肩骨头也塌陷了,专家建议置换,“但我还是不想换了,都换了成机器人了。”她笑着说。现在,62岁的毕维杰被一家私人医院返聘做了医务部主任,每天准时上下班,“生活得挺充实的”。

从SARS到MERS,这些医务工作者始终奋斗在第一线,他们是最脆弱的易感者,也是最坚强的守护者,他们的初衷从未改变,竭尽全力将伤害减至最小以保障公共卫生安全。根据广州日报报道,广东惠州中心人民医院的医护人员已抽签进入ICU特护输入性中东呼吸综合征患者,让我们向这些医护人员致敬!祝愿他们一切平安!

医护人员集合


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1878103, encodeId=ea1318e810346, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Thu Jun 11 21:38:00 CST 2015, time=2015-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321123, encodeId=41b1132112320, content=<a href='/topic/show?id=ac0d159007f' target=_blank style='color:#2F92EE;'>#SARS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15900, encryptionId=ac0d159007f, topicName=SARS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8306486, createdName=小刀医生, createdTime=Wed Jun 03 00:38:00 CST 2015, time=2015-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1338415, encodeId=269113384158b, content=<a href='/topic/show?id=767711566a9' target=_blank style='color:#2F92EE;'>#MERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11566, encryptionId=767711566a9, topicName=MERS)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/71tKRib0PibveVjnEa7tPLMaCzoKicFlKSEOzRTGf4wNvDV54kJyNx1ott1D5Xp5gRu7IwUia77oN0YFdffvQMu6Ug/132, createdBy=9e302500146, createdName=ms49895894946433513521, createdTime=Wed Jun 03 00:38:00 CST 2015, time=2015-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25703, encodeId=f39b25e03b5, content=韩国人做法让人痛恨,向天使致敬, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Dr.LV, createdTime=Mon Jun 01 15:28:00 CST 2015, time=2015-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25702, encodeId=acb825e023f, content=可怕啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Dr.LV, createdTime=Mon Jun 01 15:27:00 CST 2015, time=2015-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25688, encodeId=e50a2568885, content=向英雄们致敬!, beContent=null, objectType=article, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=934b1626634, createdName=Medxie, createdTime=Mon Jun 01 10:19:00 CST 2015, time=2015-06-01, status=1, ipAttribution=)]
    2015-06-11 仁者大医
  2. [GetPortalCommentsPageByObjectIdResponse(id=1878103, encodeId=ea1318e810346, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Thu Jun 11 21:38:00 CST 2015, time=2015-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321123, encodeId=41b1132112320, content=<a href='/topic/show?id=ac0d159007f' target=_blank style='color:#2F92EE;'>#SARS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15900, encryptionId=ac0d159007f, topicName=SARS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8306486, createdName=小刀医生, createdTime=Wed Jun 03 00:38:00 CST 2015, time=2015-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1338415, encodeId=269113384158b, content=<a href='/topic/show?id=767711566a9' target=_blank style='color:#2F92EE;'>#MERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11566, encryptionId=767711566a9, topicName=MERS)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/71tKRib0PibveVjnEa7tPLMaCzoKicFlKSEOzRTGf4wNvDV54kJyNx1ott1D5Xp5gRu7IwUia77oN0YFdffvQMu6Ug/132, createdBy=9e302500146, createdName=ms49895894946433513521, createdTime=Wed Jun 03 00:38:00 CST 2015, time=2015-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25703, encodeId=f39b25e03b5, content=韩国人做法让人痛恨,向天使致敬, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Dr.LV, createdTime=Mon Jun 01 15:28:00 CST 2015, time=2015-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25702, encodeId=acb825e023f, content=可怕啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Dr.LV, createdTime=Mon Jun 01 15:27:00 CST 2015, time=2015-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25688, encodeId=e50a2568885, content=向英雄们致敬!, beContent=null, objectType=article, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=934b1626634, createdName=Medxie, createdTime=Mon Jun 01 10:19:00 CST 2015, time=2015-06-01, status=1, ipAttribution=)]
    2015-06-03 小刀医生
  3. [GetPortalCommentsPageByObjectIdResponse(id=1878103, encodeId=ea1318e810346, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Thu Jun 11 21:38:00 CST 2015, time=2015-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321123, encodeId=41b1132112320, content=<a href='/topic/show?id=ac0d159007f' target=_blank style='color:#2F92EE;'>#SARS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15900, encryptionId=ac0d159007f, topicName=SARS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8306486, createdName=小刀医生, createdTime=Wed Jun 03 00:38:00 CST 2015, time=2015-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1338415, encodeId=269113384158b, content=<a href='/topic/show?id=767711566a9' target=_blank style='color:#2F92EE;'>#MERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11566, encryptionId=767711566a9, topicName=MERS)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/71tKRib0PibveVjnEa7tPLMaCzoKicFlKSEOzRTGf4wNvDV54kJyNx1ott1D5Xp5gRu7IwUia77oN0YFdffvQMu6Ug/132, createdBy=9e302500146, createdName=ms49895894946433513521, createdTime=Wed Jun 03 00:38:00 CST 2015, time=2015-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25703, encodeId=f39b25e03b5, content=韩国人做法让人痛恨,向天使致敬, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Dr.LV, createdTime=Mon Jun 01 15:28:00 CST 2015, time=2015-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25702, encodeId=acb825e023f, content=可怕啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Dr.LV, createdTime=Mon Jun 01 15:27:00 CST 2015, time=2015-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25688, encodeId=e50a2568885, content=向英雄们致敬!, beContent=null, objectType=article, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=934b1626634, createdName=Medxie, createdTime=Mon Jun 01 10:19:00 CST 2015, time=2015-06-01, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1878103, encodeId=ea1318e810346, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Thu Jun 11 21:38:00 CST 2015, time=2015-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321123, encodeId=41b1132112320, content=<a href='/topic/show?id=ac0d159007f' target=_blank style='color:#2F92EE;'>#SARS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15900, encryptionId=ac0d159007f, topicName=SARS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8306486, createdName=小刀医生, createdTime=Wed Jun 03 00:38:00 CST 2015, time=2015-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1338415, encodeId=269113384158b, content=<a href='/topic/show?id=767711566a9' target=_blank style='color:#2F92EE;'>#MERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11566, encryptionId=767711566a9, topicName=MERS)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/71tKRib0PibveVjnEa7tPLMaCzoKicFlKSEOzRTGf4wNvDV54kJyNx1ott1D5Xp5gRu7IwUia77oN0YFdffvQMu6Ug/132, createdBy=9e302500146, createdName=ms49895894946433513521, createdTime=Wed Jun 03 00:38:00 CST 2015, time=2015-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25703, encodeId=f39b25e03b5, content=韩国人做法让人痛恨,向天使致敬, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Dr.LV, createdTime=Mon Jun 01 15:28:00 CST 2015, time=2015-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25702, encodeId=acb825e023f, content=可怕啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Dr.LV, createdTime=Mon Jun 01 15:27:00 CST 2015, time=2015-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25688, encodeId=e50a2568885, content=向英雄们致敬!, beContent=null, objectType=article, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=934b1626634, createdName=Medxie, createdTime=Mon Jun 01 10:19:00 CST 2015, time=2015-06-01, status=1, ipAttribution=)]
    2015-06-01 Dr.LV

    韩国人做法让人痛恨,向天使致敬

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1878103, encodeId=ea1318e810346, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Thu Jun 11 21:38:00 CST 2015, time=2015-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321123, encodeId=41b1132112320, content=<a href='/topic/show?id=ac0d159007f' target=_blank style='color:#2F92EE;'>#SARS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15900, encryptionId=ac0d159007f, topicName=SARS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8306486, createdName=小刀医生, createdTime=Wed Jun 03 00:38:00 CST 2015, time=2015-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1338415, encodeId=269113384158b, content=<a href='/topic/show?id=767711566a9' target=_blank style='color:#2F92EE;'>#MERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11566, encryptionId=767711566a9, topicName=MERS)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/71tKRib0PibveVjnEa7tPLMaCzoKicFlKSEOzRTGf4wNvDV54kJyNx1ott1D5Xp5gRu7IwUia77oN0YFdffvQMu6Ug/132, createdBy=9e302500146, createdName=ms49895894946433513521, createdTime=Wed Jun 03 00:38:00 CST 2015, time=2015-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25703, encodeId=f39b25e03b5, content=韩国人做法让人痛恨,向天使致敬, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Dr.LV, createdTime=Mon Jun 01 15:28:00 CST 2015, time=2015-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25702, encodeId=acb825e023f, content=可怕啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Dr.LV, createdTime=Mon Jun 01 15:27:00 CST 2015, time=2015-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25688, encodeId=e50a2568885, content=向英雄们致敬!, beContent=null, objectType=article, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=934b1626634, createdName=Medxie, createdTime=Mon Jun 01 10:19:00 CST 2015, time=2015-06-01, status=1, ipAttribution=)]
    2015-06-01 Dr.LV

    可怕啊

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1878103, encodeId=ea1318e810346, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Thu Jun 11 21:38:00 CST 2015, time=2015-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321123, encodeId=41b1132112320, content=<a href='/topic/show?id=ac0d159007f' target=_blank style='color:#2F92EE;'>#SARS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15900, encryptionId=ac0d159007f, topicName=SARS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8306486, createdName=小刀医生, createdTime=Wed Jun 03 00:38:00 CST 2015, time=2015-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1338415, encodeId=269113384158b, content=<a href='/topic/show?id=767711566a9' target=_blank style='color:#2F92EE;'>#MERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11566, encryptionId=767711566a9, topicName=MERS)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/71tKRib0PibveVjnEa7tPLMaCzoKicFlKSEOzRTGf4wNvDV54kJyNx1ott1D5Xp5gRu7IwUia77oN0YFdffvQMu6Ug/132, createdBy=9e302500146, createdName=ms49895894946433513521, createdTime=Wed Jun 03 00:38:00 CST 2015, time=2015-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25703, encodeId=f39b25e03b5, content=韩国人做法让人痛恨,向天使致敬, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Dr.LV, createdTime=Mon Jun 01 15:28:00 CST 2015, time=2015-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25702, encodeId=acb825e023f, content=可怕啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Dr.LV, createdTime=Mon Jun 01 15:27:00 CST 2015, time=2015-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25688, encodeId=e50a2568885, content=向英雄们致敬!, beContent=null, objectType=article, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=934b1626634, createdName=Medxie, createdTime=Mon Jun 01 10:19:00 CST 2015, time=2015-06-01, status=1, ipAttribution=)]
    2015-06-01 Medxie

    向英雄们致敬!

    0

相关资讯

MERS病例飙升敲响警钟

由于担心MERS传染,利雅得球场工作人员戴口罩进行工作 图片来源:FAYEZ NURELDINE 科学家正努力弄清中东呼吸系统综合征(MERS)冠状病毒感染人数急剧增加的原因。仅在4月,沙特阿拉伯和阿拉伯联合酋长国已经报告超过200个新病例。美国疾病控制和预防中心也于5月2日通报说,该国确诊境内首位感染MERS病毒的患者,并称不排除因患者此前接触他人而造成更大范围传播

中东呼吸综合征或比SARS更致命 由骆驼传染

美国《新英格兰医学杂志》4日发表一份报告称,沙特阿拉伯研究人员发现了中东呼吸综合征(MERS)由骆驼传染给人类的第一个直接证据。 沙特卫生部3日称,2012年以来,该国因MERS死亡人数升至282人,感染人数688人(本报5月16日A20版曾有专题报道)。据悉, MERS与SARS(非典型肺炎)同属冠状病毒,会引起发烧、呼吸系统问题、肾衰竭等,已扩散至美国、荷兰等十余国,目前无法治疗,也

沙特两篇MERS 论文陷雷同风波

图片来源:M. ENSERINK 精彩的故事可以一讲再讲,论文可就不一样了。最近研究致命的中东呼吸道综合征(MERS)的科学家对两本期刊中发表的两篇论文感到困惑,这两篇论文不仅讲述了同样的内容,连其数据都来自于沙特阿拉伯的同一位病人。 分别在《新兴传染病》(EID)和《新英格兰医学杂志》(NEJM)发表的这两篇论文令两个人陷入了竞争关系——沙特阿拉伯卫生部前副部长Ziad

PLoS Pathog:开发出中东呼吸道冠状病毒易感的绒猴动物模型

近日,刊登在国际杂志PLoS Pathogens上的一篇研究论文中,来自国家过敏症和传染病研究所的就人员通过研究首次开发出了可以模拟中东呼吸道冠状病毒(MERS-CoV)感染症状的动物模型,这为开发治疗该病毒感染的新型疗法和药物提供了新的研究思路。 文章中,研究者揭示了MERS-CoV如何识别并且侵入人类细胞,该病毒可以利用其表面的突起蛋白来结合人类细胞表面名为DPP4的蛋白,从而使得病毒

首例MERS冠状病毒现身美国

MERS的新型冠状病毒在中东地区不断扩大感染面积,MERS冠状病毒与SARS属于同一种类,美国也在近日发现了首例感染患者。该病毒自2012年首次确诊以来,在中东地区爆发,至今已有100多人被病毒夺去生命。 美国CDC(疾病控制与预防中心)于5月2日向公众宣布,美国疾控中心上周派出一组传染病专家,前往印地安纳州一家医院,因这里报告美国首例中东呼吸综合征冠状病毒(MERS,类SARS

WHO:MERS疫情尚未进入紧急状态

世界卫生组织14日发布声明说,该机构针对全球新型冠状病毒(中东呼吸系统综合征冠状病毒,MERS)疫情召开了紧急委员会会议。该委员会认为,尚未有证据表明这种病毒能在人际间持续传播,因此目前仍不构成“国际关注的公共卫生紧急事件”。 世卫组织根据2007年生效的《国际卫生条例》,已先后举行五次研讨新型冠状病毒疫情的紧急委员会远程会议。在综合评估各方信息后,与会委员认为,就新型冠状病毒对全球公共卫生

Baidu
map
Baidu
map
Baidu
map